{"id":165,"date":"2021-11-17T18:54:55","date_gmt":"2021-11-17T18:54:55","guid":{"rendered":"https:\/\/sites.dundee.ac.uk\/sddc\/?page_id=165"},"modified":"2026-04-09T19:59:21","modified_gmt":"2026-04-09T18:59:21","slug":"contact-details","status":"publish","type":"page","link":"https:\/\/sites.dundee.ac.uk\/sddc\/contact-details\/","title":{"rendered":"Contact details"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Drug Discovery Unit<\/h2>\n\n\n\n<p>Barbara Forte, Medicinal chemistry team leader\/SDDC Projects manager<\/p>\n\n\n\n<p><a href=\"mailto:bforte@dundee.ac.uk\">bforte@dundee.ac.uk<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Other Key Contacts<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Drug Discovery Unit<\/h3>\n\n\n\n<p>Ian Gilbert, Head of the Division of Biological Chemistry and Drug Discovery, <a href=\"mailto:i.h.gilbert@dundee.ac.uk\">i.h.gilbert@dundee.ac.uk<\/a><\/p>\n\n\n\n<p>Beatriz Baragana, Apicomplexan Portfolio Manager, <a href=\"mailto:B.Baragana@dundee.ac.uk\">B.Baragana@dundee.ac.uk<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">SSGCID &#8211; University of Washington &#8211; Seattle<\/h3>\n\n\n\n<p>Wes Van Voorhis, Director, Center for Emerging and Re-emerging Infectious Diseases (CERID), <a href=\"mailto:WVanVoorhis@medicine.washington.edu\">WVanVoorhis@medicine.washington.edu<\/a><\/p>\n\n\n\n<p>Peter J Myler, Director, Seattle Structural Genomics Center for Infectious Disease,&nbsp;<a href=\"mailto:peter.myler@seattlechildrens.org\">peter.myler@seattlechildrens.or<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CSBID- \u00a0Argonne National Laboratory<\/h3>\n\n\n\n<p>Andrzej Joachimiak, Director of Structural Biology Center and Midwest Center for Structural Genomics, <a href=\"mailto:andrzejj@anl.gov\">andrzejj@anl.gov<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CQMED-UNICAMP<\/h3>\n\n\n\n<p>Rafael M. Cou\u00f1ago, <a href=\"mailto:rafael.counago@unicamp.br\">rafael.counago@unicamp.br<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drug Discovery Unit Barbara Forte, Medicinal chemistry team leader\/SDDC Projects manager bforte@dundee.ac.uk Other Key Contacts Drug Discovery Unit Ian Gilbert, Head of the Division of Biological Chemistry and Drug Discovery, i.h.gilbert@dundee.ac.uk Beatriz Baragana, Apicomplexan Portfolio Manager, B.Baragana@dundee.ac.uk SSGCID &#8211; University of Washington &#8211; Seattle Wes Van Voorhis, Director, Center for Emerging and Re-emerging Infectious Diseases [&hellip;]<\/p>\n","protected":false},"author":131,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-165","page","type-page","status-publish","hentry"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/pages\/165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/comments?post=165"}],"version-history":[{"count":28,"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/pages\/165\/revisions"}],"predecessor-version":[{"id":517,"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/pages\/165\/revisions\/517"}],"wp:attachment":[{"href":"https:\/\/sites.dundee.ac.uk\/sddc\/wp-json\/wp\/v2\/media?parent=165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}